Non-Current Assets
Equity Securities Without Readily Determinable Fair Value - Cumulative Upward Adjustments
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2026
Last reportedQ1 2026
How to read this metric
An increase indicates successful investment performance and growth in the value of private holdings, while a decrease suggests stagnation or lack of appreciation.
Detailed definition
Represents the cumulative total of upward valuation adjustments applied to equity investments that lack a readily determ...
Peer comparison
Standard metric for banks and investment firms that hold significant non-marketable equity stakes.
Metric ID:
equity_securities_no_fv_upward_adjHistorical Data
1 periods
| Q1 '26 | |
|---|---|
| Value | $320.00M |
Equity Securities Without Readily Determinable Fair Value - Cumulative Upward Adjustments at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s equity securities without readily determinable fair value - cumulative upward adjustments?
- Merck & Co. (MRK) reported equity securities without readily determinable fair value - cumulative upward adjustments of $320.00M in Q1 2026.
- What does equity securities without readily determinable fair value - cumulative upward adjustments mean?
- The total amount of value gained on private or non-marketable equity investments due to upward price adjustments.